Growth Hormone & IGF
GHRH analogues, secretagogues and growth-factor research.
14 products
GH & IGFCND2CJC-1295 Without DAC
A modified 29-amino-acid fragment of growth hormone-releasing hormone, engineered to resist the rapid enzymatic breakdown that limits the native peptide.
3 sizes · 2mg–10mg- GH & IGFCD2
CJC-1295 With DAC
A GHRH analogue fitted with a drug affinity complex that binds circulating albumin, extending its half-life from minutes to several days.
2 sizes · 2mg–5mg - GH & IGFCP10
CJC-1295 Without DAC 5mg + IPA 5mg
A combination of modified GRF (1-29) and ipamorelin, pairing the two receptor pathways that drive pituitary growth hormone release.
10mg*10vials - GH & IGFIP5
Ipamorelin
A synthetic pentapeptide that stimulates growth hormone release through the ghrelin receptor, noted in early work for its selectivity.
2 sizes · 5mg–10mg - GH & IGFSMO5
Sermorelin
The 29-amino-acid active fragment of growth hormone-releasing hormone, formerly approved in the US for growth hormone deficiency in children.
2 sizes · 5mg–10mg - GH & IGFTSM5
Tesamorelin
A full-length GHRH analogue approved in the US for reducing excess abdominal fat in HIV-associated lipodystrophy, and studied for liver fat.
3 sizes · 5mg–20mg - GH & IGFG25
GHRP-2 Acetate
A synthetic hexapeptide growth hormone secretagogue, approved in Japan as a diagnostic agent for adult growth hormone deficiency.
2 sizes · 5mg–10mg - GH & IGFG65
GHRP-6 Acetate
One of the first synthetic growth hormone-releasing peptides, a hexapeptide whose study led to the identification of the ghrelin receptor.
2 sizes · 5mg–10mg - GH & IGFHX5
Hexarelin Acetate
A potent synthetic hexapeptide GH secretagogue that also binds a cardiac receptor, CD36, which made it a subject of cardiovascular research.
5mg*10vials - GH & IGF
HGH Frag 176-191
A synthetic peptide from the C-terminal region of human growth hormone, studied for effects on fat metabolism separate from GH's growth actions.
5mg*10vials - GH & IGFIG01
IGF-1 LR3
An 83-amino-acid analogue of insulin-like growth factor I engineered to bind poorly to IGF-binding proteins, which increases its biological potency in vitro and in animals.
2 sizes · 0.1mg–1mg - GH & IGFFM2
MGF
A peptide based on the C-terminal E-domain of IGF-1Ec, a splice variant first identified in muscle subjected to stretch. Its biological role is disputed.
2ml*10vials - GH & IGF
Follistatin
A naturally occurring glycoprotein that binds and neutralizes myostatin and activin, studied mainly through gene therapy approaches in muscle disease.
1mg*10vials - GH & IGFAE1
ACE-031
A fusion protein of the activin type IIB receptor and an antibody Fc fragment that traps myostatin and related ligands. It was tested in Duchenne muscular dystrophy before its trial was stopped.
1ml*10vials